20-44619661-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000022.4(ADA):c.*173G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00338 in 801,538 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 50 hom., cov: 33)
Exomes 𝑓: 0.0014 ( 16 hom. )
Consequence
ADA
NM_000022.4 3_prime_UTR
NM_000022.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.13
Genes affected
ADA (HGNC:186): (adenosine deaminase) This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine in the purine catabolic pathway. Various mutations have been described for this gene and have been linked to human diseases related to impaired immune function such as severe combined immunodeficiency disease (SCID) which is the result of a deficiency in the ADA enzyme. In ADA-deficient individuals there is a marked depletion of T, B, and NK lymphocytes, and consequently, a lack of both humoral and cellular immunity. Conversely, elevated levels of this enzyme are associated with congenital hemolytic anemia. [provided by RefSeq, Sep 2019]
PKIG (HGNC:9019): (cAMP-dependent protein kinase inhibitor gamma) This gene encodes a member of the protein kinase inhibitor family. Studies of a similar protein in mice suggest that this protein acts as a potent competitive cAMP-dependent protein kinase inhibitor, and is a predominant form of inhibitor in various tissues. The encoded protein may be involved in osteogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 20-44619661-C-G is Benign according to our data. Variant chr20-44619661-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 338502.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0118 (1794/152292) while in subpopulation AFR AF= 0.0411 (1706/41544). AF 95% confidence interval is 0.0394. There are 50 homozygotes in gnomad4. There are 831 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 50 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADA | NM_000022.4 | c.*173G>C | 3_prime_UTR_variant | 12/12 | ENST00000372874.9 | NP_000013.2 | ||
ADA | NM_001322051.2 | c.*173G>C | 3_prime_UTR_variant | 11/11 | NP_001308980.1 | |||
ADA | NM_001322050.2 | c.*173G>C | 3_prime_UTR_variant | 11/11 | NP_001308979.1 | |||
ADA | NR_136160.2 | n.1292G>C | non_coding_transcript_exon_variant | 11/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADA | ENST00000372874 | c.*173G>C | 3_prime_UTR_variant | 12/12 | 1 | NM_000022.4 | ENSP00000361965.4 | |||
ADA | ENST00000695995 | c.*173G>C | 3_prime_UTR_variant | 9/9 | ENSP00000512318.1 | |||||
ADA | ENST00000695991 | c.*173G>C | 3_prime_UTR_variant | 8/8 | ENSP00000512314.1 | |||||
ADA | ENST00000695956 | c.*57G>C | 3_prime_UTR_variant | 3/3 | ENSP00000512285.1 | |||||
ADA | ENST00000696038.1 | n.*1473G>C | non_coding_transcript_exon_variant | 9/9 | ENSP00000512344.1 | |||||
ADA | ENST00000696038.1 | n.*1473G>C | 3_prime_UTR_variant | 9/9 | ENSP00000512344.1 |
Frequencies
GnomAD3 genomes AF: 0.0118 AC: 1794AN: 152174Hom.: 50 Cov.: 33
GnomAD3 genomes
AF:
AC:
1794
AN:
152174
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00142 AC: 919AN: 649246Hom.: 16 Cov.: 9 AF XY: 0.00116 AC XY: 393AN XY: 338980
GnomAD4 exome
AF:
AC:
919
AN:
649246
Hom.:
Cov.:
9
AF XY:
AC XY:
393
AN XY:
338980
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0118 AC: 1794AN: 152292Hom.: 50 Cov.: 33 AF XY: 0.0112 AC XY: 831AN XY: 74458
GnomAD4 genome
AF:
AC:
1794
AN:
152292
Hom.:
Cov.:
33
AF XY:
AC XY:
831
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at